777 related articles for article (PubMed ID: 25746843)
1. Model of mucociliary clearance in cystic fibrosis lungs.
Kurbatova P; Bessonov N; Volpert V; Tiddens HA; Cornu C; Nony P; Caudri D;
J Theor Biol; 2015 May; 372():81-8. PubMed ID: 25746843
[TBL] [Abstract][Full Text] [Related]
2. Introduction to section I: overview of approaches to study cystic fibrosis pathophysiology.
Clunes MT; Boucher RC
Methods Mol Biol; 2011; 742():3-14. PubMed ID: 21547723
[TBL] [Abstract][Full Text] [Related]
3. Cystic fibrosis: a disease of vulnerability to airway surface dehydration.
Boucher RC
Trends Mol Med; 2007 Jun; 13(6):231-40. PubMed ID: 17524805
[TBL] [Abstract][Full Text] [Related]
4. Airway mucus in cystic fibrosis.
Puchelle E; Bajolet O; Abély M
Paediatr Respir Rev; 2002 Jun; 3(2):115-9. PubMed ID: 12297057
[TBL] [Abstract][Full Text] [Related]
5. Cystic fibrosis lung disease starts in the small airways: can we treat it more effectively?
Tiddens HA; Donaldson SH; Rosenfeld M; Paré PD
Pediatr Pulmonol; 2010 Feb; 45(2):107-17. PubMed ID: 20082341
[TBL] [Abstract][Full Text] [Related]
6. Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis.
Hoegger MJ; Fischer AJ; McMenimen JD; Ostedgaard LS; Tucker AJ; Awadalla MA; Moninger TO; Michalski AS; Hoffman EA; Zabner J; Stoltz DA; Welsh MJ
Science; 2014 Aug; 345(6198):818-22. PubMed ID: 25124441
[TBL] [Abstract][Full Text] [Related]
7. Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH.
Hill DB; Long RF; Kissner WJ; Atieh E; Garbarine IC; Markovetz MR; Fontana NC; Christy M; Habibpour M; Tarran R; Forest MG; Boucher RC; Button B
Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30361244
[TBL] [Abstract][Full Text] [Related]
8. Progress in understanding mucus abnormalities in cystic fibrosis airways.
Wine JJ; Hansson GC; König P; Joo NS; Ermund A; Pieper M
J Cyst Fibros; 2018 Mar; 17(2S):S35-S39. PubMed ID: 28951068
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic options for hydrating airway mucus in cystic fibrosis.
Tildy BE; Rogers DF
Pharmacology; 2015; 95(3-4):117-32. PubMed ID: 25823699
[TBL] [Abstract][Full Text] [Related]
10. Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis.
Hodson ME
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S70-4. PubMed ID: 7881698
[TBL] [Abstract][Full Text] [Related]
11. TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis.
Danahay HL; Lilley S; Fox R; Charlton H; Sabater J; Button B; McCarthy C; Collingwood SP; Gosling M
Am J Respir Crit Care Med; 2020 Apr; 201(8):946-954. PubMed ID: 31898911
[No Abstract] [Full Text] [Related]
12. Cystic fibrosis and other respiratory diseases of impaired mucus clearance.
Livraghi A; Randell SH
Toxicol Pathol; 2007 Jan; 35(1):116-29. PubMed ID: 17325980
[TBL] [Abstract][Full Text] [Related]
13. Development of an airway mucus defect in the cystic fibrosis rat.
Birket SE; Davis JM; Fernandez CM; Tuggle KL; Oden AM; Chu KK; Tearney GJ; Fanucchi MV; Sorscher EJ; Rowe SM
JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321377
[TBL] [Abstract][Full Text] [Related]
14. Numerical and experimental investigation of mucociliary clearance breakdown in cystic fibrosis.
Chatelin R; Anne-Archard D; Murris-Espin M; Thiriet M; Poncet P
J Biomech; 2017 Feb; 53():56-63. PubMed ID: 28117099
[TBL] [Abstract][Full Text] [Related]
15. Rationale for hypertonic saline therapy for cystic fibrosis lung disease.
Tarran R; Donaldson S; Boucher RC
Semin Respir Crit Care Med; 2007 Jun; 28(3):295-302. PubMed ID: 17562499
[TBL] [Abstract][Full Text] [Related]
16. Role of CFTR in airway disease.
Pilewski JM; Frizzell RA
Physiol Rev; 1999 Jan; 79(1 Suppl):S215-55. PubMed ID: 9922383
[TBL] [Abstract][Full Text] [Related]
17. Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets.
Haq IJ; Gray MA; Garnett JP; Ward C; Brodlie M
Thorax; 2016 Mar; 71(3):284-7. PubMed ID: 26719229
[TBL] [Abstract][Full Text] [Related]
18. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy.
Boucher RC
Annu Rev Med; 2007; 58():157-70. PubMed ID: 17217330
[TBL] [Abstract][Full Text] [Related]
19. Physical and functional properties of airway secretions in cystic fibrosis--therapeutic approaches.
Puchelle E; de Bentzmann S; Zahm JM
Respiration; 1995; 62 Suppl 1():2-12. PubMed ID: 7792436
[TBL] [Abstract][Full Text] [Related]
20. A glycopolymer improves vascoelasticity and mucociliary transport of abnormal cystic fibrosis mucus.
Fernandez-Petty CM; Hughes GW; Bowers HL; Watson JD; Rosen BH; Townsend SM; Santos C; Ridley CE; Chu KK; Birket SE; Li Y; Leung HM; Mazur M; Garcia BA; Evans TIA; Libby EF; Hathorne H; Hanes J; Tearney GJ; Clancy JP; Engelhardt JF; Swords WE; Thornton DJ; Wiesmann WP; Baker SM; Rowe SM
JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
